Clinically Insignificant Effect of Alemtuzumab Infusions on Vital Signs: A Prospective Observational Study in Patients with Relapsing-Remitting Multiple Sclerosis

Angel Chinea,William David Honeycutt,Tamara Miller,Donna Graves,Alan Jacobs,Junlong Wu,Christopher LaGanke

Clinically Insignificant Effect of Alemtuzumab Infusions on Vital Signs: A Prospective Observational Study in Patients with Relapsing-Remitting Multiple Sclerosis

2019

Angel Chinea
William David Honeycutt
Tamara Miller
Donna Graves
Alan Jacobs
Junlong Wu
Christopher LaGanke

Abstract Background: Alemtuzumab efficacy and safety were established in phase 3 randomized trials. Here, we characterize vital signs during and after infusion of the first alemtuzumab course. Meth...

Keywords:

Alemtuzumab
Observational study
Multiple sclerosis
Vital signs
Internal medicine
Medicine
in patient
Randomized controlled trial
Meth-
relapsing remitting

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations